102. Tocilizumb did not Significantly Increase Serum Cholesterol Levels in Healthy Subjects
Author
Grange, Susan. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Schmitt, Christophe. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Ganeshalingam, Kandeepan. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Choy, Ernest H.. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Document Type
Postprint
Language
English
Published in
Rheumatology, 2014, vol. 53, p. i95-i96. Oxford University Press